Optimization of the Redox-Sensitive Doxorubicin Loaded Chitosan-based Nanoparticles by Box–Behnken Experimental Design

Author:

Babaei Mahsa1,Kashanian Soheila1,Salemi Zahra2

Affiliation:

1. Razi University

2. Arak University of Medical Sciences

Abstract

Abstract Background Developing a satisfactory approach for delivering the chemotherapeutic drugs is one of the critical points in cancer treatment. Box–Behnken Design (BBD) is a Response Surface Methodology (RSM) that investigates the significant effects of various independent factors on dependent variables and also covers all potential effects of their interactions only by three levels of each factor. Methods and Results In this study, a Crosslinked Chitosan-L-Cysteine (Cs-Cys)/Tripolyphosphate (TPP) Nanoparticles (Cs-CysNPs) was synthesized to load Doxorubicin (DOX) (Cs-CysNPs-DOX) into a polymeric matrix as a promising redox responsive NP for breast cancer treatment. A statistical optimization by BBD was employed to examine the effects of the essential variables (CS-Cys concentration, TPP concentration, and Cs-Cys/TPP ratio) to optimize the Entrapment Efficiency (EE%) as the dependent variable. The optimized formulations with high EE% were obtained at middle levels of Cs-Cys concentration (1.25 mg/ml), Cs-Cys/TPP ratio (6:1) and high levels of the TPP concentration. The optimized Cs-CysNPs-DOX showed enhanced EE% and Drug Loading (DL%) compared to CsNPs. Also, they had an average hydrodynamic size of 144.55 nm and a Polydispersity Index (PDI) of 0.262, which showed a resealable size with sufficient PDI. Also, the final formulation of NPs had a positive zeta potential, which caused the high stability of the suspension. Conclusions Consequently, the optimized Cs-Cys NPs could be investigated as a suitable carrier for DOX entrapment and delivery to breast cancer cells.

Publisher

Research Square Platform LLC

Reference25 articles.

1. Nanocarriers for anticancer drugs: Challenges and perspectives;Alqosaibi AI;Saudi J Biol Sci,2022

2. aC. Carvalho SRX, Cardoso S, Correia S, Oliveira PJ, Santos MS, Moreira PI Doxorubicin: the good, the bad and the ugly effect. Current medicinal chemistry 16: 3267–3285., Wenningmann bN, Ande KM, Vaidya A, Ait-Oudhia TR (2009) S. (2019) Insights into doxorubicin-induced cardiotoxicity: molecular mechanisms, preventive strategies, and early monitoring. Molecular pharmacology 96: 219–232. https://doi.org/10.1124/mol.119.115725

3. Inhibition of carbonyl reductase 1 safely improves the efficacy of doxorubicin in breast cancer treatment;Jo A;Antioxid Redox Signal,2017

4. aE. Rahmani PM, Ghorbanian SA, Yazdian F, Rashedi H, Navaee M Preparation of a pH-responsive chitosan-montmorillonite-nitrogen-doped carbon quantum dots nanocarrier for attenuating doxorubicin limitations in cancer therapy. Engineering in life sciences 22: 634–649., bB. Shankar JP, Saikrishna B, Perugu S, Manga V (2022) (2018) Synthesis, anti-microbial activity, cytotoxicity of some novel substituted (5-(3-(1H-benzo[d]imidazol-2-yl)-4-hydroxybenzyl)benzofuran-2-yl)(phenyl)methanone analogs. Chemistry Central journal 12: 1. https://doi.org/10.1186/s13065-017-0364-3

5. Butowska K, Woziwodzka A, Borowik A, Piosik J (2021) Polymeric Nanocarriers: A Transformation in Doxorubicin Therapies. Materials (Basel, Switzerland) 14. http://dx.doi.org/10.20944/preprints202103.0095.v1

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3